ImageneBio (IMA)
NASDAQ:IMA
Total Valuation
ImageneBio has a market cap or net worth of $55.92M. The enterprise value is $30.95M.
Market Cap$55.92M
Enterprise Value$30.95M
Share Statistics
ImageneBio has 10,654,281 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,654,281
Owned by Insiders30.60%
Owned by Institutions36.06%
Financial Efficiency
ImageneBio’s return on equity (ROE) is -0.34 and return on invested capital (ROIC) is -33.39%.
Return on Equity (ROE)-0.34
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-33.39%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee80.00K
Profits Per Employee-5.24M
Employee Count10
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ImageneBio is ―. ImageneBio’s PEG ratio is -0.00078.
PE Ratio―
PS Ratio42.01
PB Ratio0.25
Price to Fair Value0.25
Price to FCF-0.70
Price to Operating Cash Flow-1.17
PEG Ratio-0.00078
Income Statement
In the last 12 months, ImageneBio had revenue of 800.00K and earned -45.35M in profits. Earnings per share was -10.76.
Revenue800.00K
Gross Profit-233.00K
Operating Income-48.45M
Pretax Income-45.70M
Net Income-45.35M
EBITDA-47.42M
Earnings Per Share (EPS)-10.76
Cash Flow
In the last 12 months, operating cash flow was -47.84M and capital expenditures 0.00, giving a free cash flow of -47.84M billion.
Operating Cash Flow-47.84M
Free Cash Flow-47.84M
Free Cash Flow per Share-4.49
Dividends & Yields
ImageneBio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change-67.45%
50-Day Moving Average6.50
200-Day Moving Average9.61
Relative Strength Index (RSI)27.43
Average Volume (3m)69.52K
Important Dates
ImageneBio upcoming earnings date is Mar 10, 2026, Before Open (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateMar 10, 2026
Ex-Dividend Date―
Financial Position
ImageneBio as a current ratio of 12.49, with Debt / Equity ratio of 7.51%
Current Ratio12.49
Quick Ratio12.49
Debt to Market Cap0.21
Net Debt to EBITDA0.53
Interest Coverage Ratio0.00
Taxes
In the past 12 months, ImageneBio has paid -350.00K in taxes.
Income Tax-350.00K
Effective Tax Rate<0.01
Enterprise Valuation
ImageneBio EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -0.18.
EV to Sales10.80
EV to EBITDA-0.18
EV to Free Cash Flow-0.18
EV to Operating Cash Flow-0.18
Balance Sheet
ImageneBio has $75.78M in cash and marketable securities with $9.99M in debt, giving a net cash position of $65.79M billion.
Cash & Marketable Securities$75.78M
Total Debt$9.99M
Net Cash$65.79M
Net Cash Per Share$6.17
Tangible Book Value Per Share$27.33
Margins
Gross margin is 0.00%, with operating margin of -6056.38%, and net profit margin of -5668.63%.
Gross Margin0.00%
Operating Margin-6056.38%
Pretax Margin-5712.38%
Net Profit Margin-5668.63%
EBITDA Margin-5927.25%
EBIT Margin-6056.38%
Analyst Forecast
The average price target for ImageneBio is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$2.00
Price Target Upside-60.00% Downside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast-100.00%
EPS Growth Forecast45.48%